ANIL KHANDELWAL: Open Payments
NPI 1669630356 · PLAINFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 45 payments from 14 companies in 2025. Trend: 2023 $1,230 · 2024 $1,139 · 2025 $1,601
Food & beverage: $1,601
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $250 |
| ViiV Healthcare Company | 16 | $233 |
| AstraZeneca Pharmaceuticals LP | 2 | $199 |
| Novo Nordisk Inc | 5 | $182 |
| Madrigal Pharmaceuticals | 1 | $135 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Amgen Inc. | 2 | $116 |
| Gilead Sciences, Inc. | 5 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $84 |
| Theratechnologies Inc. | 3 | $52 |
Products named: AIRSUPRA, CABENUVA, Ozempic, REZDIFFRA, QULIPTA, SKYRIZI, AREXVY, REPATHA.
Industry payments across NJ — which companies pay providers there.
